BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 27265844)

  • 1. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
    Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
    Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
    Magnussen LV
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
    Magnussen LV; Hvid LG; Hermann AP; Hougaard DM; Gram B; Caserotti P; Andersen MS
    Andrology; 2017 Sep; 5(5):946-953. PubMed ID: 28914503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria, glycogen, and lipid droplets in skeletal muscle during testosterone treatment and strength training: a randomized, double-blinded, placebo-controlled trial.
    Jensen RC; Christensen LL; Nielsen J; Schrøder HD; Kvorning T; Gejl K; Højlund K; Glintborg D; Andersen M
    Andrology; 2018 Jul; 6(4):547-555. PubMed ID: 29656500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone therapy increased muscle mass and lipid oxidation in aging men.
    Frederiksen L; Højlund K; Hougaard DM; Brixen K; Andersen M
    Age (Dordr); 2012 Feb; 34(1):145-56. PubMed ID: 21347608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR spectroscopy of hepatic fat and adiponectin and leptin levels during testosterone therapy in type 2 diabetes: a randomized, double-blinded, placebo-controlled trial.
    Magnussen LV; Andersen PE; Diaz A; Ostojic J; Højlund K; Hougaard DM; Christensen AN; Nielsen TL; Andersen M
    Eur J Endocrinol; 2017 Aug; 177(2):157-168. PubMed ID: 28522646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
    Herrmann BL; Berg C; Vogel E; Nowak T; Renzing-Koehler K; Mann K; Saller B
    Horm Metab Res; 2004 Jan; 36(1):54-61. PubMed ID: 14983408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
    Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
    Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
    Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
    Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone therapy decreases subcutaneous fat and adiponectin in aging men.
    Frederiksen L; Højlund K; Hougaard DM; Mosbech TH; Larsen R; Flyvbjerg A; Frystyk J; Brixen K; Andersen M
    Eur J Endocrinol; 2012 Mar; 166(3):469-76. PubMed ID: 22190001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
    Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
    Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR; Sorkin JD; Münzer T; Bellantoni MF; Busby-Whitehead J; Stevens TE; Jayme J; O'Connor KG; Christmas C; Tobin JD; Stewart KJ; Cottrell E; St Clair C; Pabst KM; Harman SM
    JAMA; 2002 Nov; 288(18):2282-92. PubMed ID: 12425705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
    Kapoor D; Goodwin E; Channer KS; Jones TH
    Eur J Endocrinol; 2006 Jun; 154(6):899-906. PubMed ID: 16728551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review.
    Nightingale TE; Moore P; Harman J; Khalil R; Gill RS; Castillo T; Adler RA; Gorgey AS
    J Spinal Cord Med; 2018 Nov; 41(6):624-636. PubMed ID: 28770686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
    Emmelot-Vonk MH; Verhaar HJ; Nakhai Pour HR; Aleman A; Lock TM; Bosch JL; Grobbee DE; van der Schouw YT
    JAMA; 2008 Jan; 299(1):39-52. PubMed ID: 18167405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
    Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
    Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-body oxidative stress reduction during testosterone therapy in aging men: A randomized placebo-controlled trial.
    Christensen LL; Poulsen HE; Andersen MS; Glintborg D
    Andrology; 2024 Jan; 12(1):115-122. PubMed ID: 37177884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
    JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.